- Acute myeloid leukaemia2013 | First Faculty of Medicine
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- PHF6 mutations in paediatric acute myeloid leukaemia2016 | Second Faculty of Medicine
- Blast phase of chronic myeloid leukaemia2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia2013 | Second Faculty of Medicine
- Differences in cyto- and molecular genetic aberrations between children < 2 years and older children with acute myeloid leukaemiaPublication without faculty affiliation
- Chronic myeloid leukaemia - standardization of BCR-ABL1 transcript level monitoring in the Czech Republic2016 | Publication without faculty affiliation
- CBL mutations do not frequently occur in paediatric acute myeloid leukaemia2012 | Second Faculty of Medicine
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study2010 | Second Faculty of Medicine
- Basophils in myeloid leukaemia may exhibit dipeptidylpeptidase IV2000 | First Faculty of Medicine
- Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission2020 | First Faculty of Medicine, Second Faculty of Medicine
- First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial2018 | Publication without faculty affiliation
- Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients2019 | Publication without faculty affiliation
- Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study2021 | Faculty of Medicine in Hradec Králové
- Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study2020 | Second Faculty of Medicine
- Acute myeloid leukaemia (AML) +12009 | Faculty of Medicine in Hradec Králové
- Health-related quality of life in acute myeloid leukaemia and multiple myeloma survivors undergoing autologous progenitor stem cell transplantation: a retrospective analysis2007 | First Faculty of Medicine
- Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA registry2011 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Skin manifestations of acute myeloid leukaemia1998 | Second Faculty of Medicine, Central Library of Charles University
- Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation2017 | Publication without faculty affiliation
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- The Relationship of Kynurenine and Neopterin Levels and Their Association with a Selection of Other Immune Markers in Chronic Myeloid Leukaemia Patients2016 | Faculty of Pharmacy in Hradec Králové
- Immunological Profiles of Patients with Chronic Myeloid Leukaemia. I. State before the Start of Treatment2006 | First Faculty of Medicine
- Immunological Profiles of Patients with Chronic Myeloid Leukaemia. I. State before the Start of Treatment2006 | Faculty of Physical Education and Sport
- Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium2020 | Faculty of Medicine in Pilsen
- The Relapsed AML 2001/01, 02 Study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome2011 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Midostaurin - the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation2022 | First Faculty of Medicine
- Symposium and workshop - actual challenges and implementation of new technologies in the treatment of chronic myeloid leukaemia2023 | First Faculty of Medicine